Toumaz Technology co-founder wins 2009 World Technology Award for
Health and Medicine
7 August 2009
Toumaz Technology Limited, a provider of ultra-low power wireless
infrastructure for body-monitoring solutions, has announced that its
co-founder, Chairman and Chief Technology Officer Professor Chris
Toumazou FRS (photo on right) has won the 2009 World Technology Award in the Health and
Medicine category.
Professor Toumazou, who is also CEO of Toumaz Holdings, was named as
this year’s recipient at a gala ceremony last month. The award ceremony
was held at the TIME Conference Center, Time and Life Building, in New
York, at the culmination of the two-day World Technology Summit.
The prestigious World Technology Awards are given in recognition of
those individuals and companies doing innovative work of "the greatest
likely long-term significance" in their respective fields. Nominees are
proposed by Fellows and Founding Members of the World Technology Network
(WTN) — a global community of the key players working in technology,
from technologists, financiers and entrepreneurs to government
officials, policy analysts and futurists.
Other recipients of an Individual award this year include Facebook
Founder and CEO Mark Zuckerberg and President Paul Kagame of the
Republic of Rwanda. Corporate winners include YouTube (in the category
of Communications Technology), Amazon (IT Hardware) and Facebook (IT
Software). The corporate winner in the Health and Medicine category was
the Mayo Clinic.
World Technology Network Founder and Chairman James P Clark
commented: “The World Technology Network was conceived to bring together
the most innovative and impactful people and organisations in science
and technology today.
"Professor Chris Toumazou is a great example of an extraordinary
individual working tirelessly on technologies and businesses that are
actively creating the future, as exemplified by the pioneering digital
band-aid healthcare product now entering the market through Toumaz
Technology. Professor Toumazou’s achievements have been wholeheartedly
endorsed by his peers through this award, and we are delighted to
welcome him to the association.”
Professor Toumazou said, “I am very grateful to the members of the
World Technology Network for this honour. The focus of my professional
endeavour has always has been to accelerate the development and adoption
of technology that can benefit and improve the lives of people around
the world. I am delighted to become a part of a community of innovators
that share this vision.”
Professor Toumazou co-founded Toumaz Technology in 2000 to exploit
developments in ultra-low power silicon chip technology at Imperial
College London. The patented core technology, advanced mixed signal
processing (AMx), is the basis for Toumaz’s Sensium technology platform
for intelligent, ultra-low power wireless body monitoring.
Professor Toumazou currently holds the Winston Wong Chair in
Biomedical Circuits at Imperial College London and is Director and Chief
Scientist of the new Institute of Biomedical Engineering at Imperial. In
recognition of his outstanding research, he was made a Professor at
Imperial College at the age of 33 — one of the youngest ever. He holds
23 patents, many of which are now fully granted in key territories
throughout the world, and has published over 320 research papers in the
field of RF and low power electronics.
In 2007 he was awarded the Royal Academy of Engineering Silver Medal
and in 2008 was elected as a Fellow of the Royal Society — the highest
honour in the UK scientific system.
Professor Toumazou led a major campaign to raise £22 million to fund
the creation of the Institute of Biomedical Engineering at Imperial
College London, which opened its state-of-the-art, purpose-built
facilities in 2006. By combining the strengths of Imperial’s world class
research schools in engineering and medicine, the IBE draws together
scientists, medical researchers, clinicians and engineers to drive major
advances in key areas of medical diagnosis and treatment, including
personalised healthcare, regenerative medicine and biomedical imaging.
Bookmark this page